RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,710,152 | $1,076,130 | $767,775 | $1,423,902 |
| % Growth | 58.9% | 40.2% | -46.1% | – |
| Cost of Goods Sold | $342,796 | $253,136 | $269,939 | $67,163 |
| Gross Profit | $1,367,356 | $822,994 | $497,836 | $1,356,739 |
| % Margin | 80% | 76.5% | 64.8% | 95.3% |
| R&D Expenses | $1,539,778 | $1,306,307 | $982,080 | $710,973 |
| G&A Expenses | $332,284 | $313,673 | $272,542 | $219,840 |
| SG&A Expenses | $1,281,039 | $1,088,858 | $713,238 | $482,807 |
| Sales & Mktg Exp. | $948,755 | $775,185 | $440,696 | $262,967 |
| Other Operating Expenses | -$82,633 | -$69,825 | -$143,403 | $121 |
| Operating Expenses | $2,738,184 | $2,325,340 | $1,551,915 | $1,193,901 |
| Operating Income | -$1,370,828 | -$1,502,346 | -$1,054,079 | $162,838 |
| % Margin | -80.2% | -139.6% | -137.3% | 11.4% |
| Other Income/Exp. Net | -$97,534 | -$8,883 | $55,249 | $113,420 |
| Pre-Tax Income | -$1,468,362 | -$1,511,229 | -$998,830 | $276,258 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,468,362 | -$1,511,229 | -$998,830 | $276,258 |
| % Margin | -85.9% | -140.4% | -130.1% | 19.4% |
| EPS | -2.73 | -2.8 | -1.88 | 0.57 |
| % Growth | 2.5% | -48.9% | -429.8% | – |
| EPS Diluted | -2.73 | -2.8 | -1.88 | 0.57 |
| Weighted Avg Shares Out | 537,393 | 539,725 | 530,120 | 487,443 |
| Weighted Avg Shares Out Dil | 537,525 | 539,725 | 531,155 | 487,443 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10,239 | $28,143 | $61,543 | $43,348 |
| Interest Expense | $72,379 | $23,091 | $6,757 | $5,323 |
| Depreciation & Amortization | $300,609 | $240,279 | $186,371 | $120,472 |
| EBITDA | -$1,095,374 | -$1,247,859 | -$805,702 | $402,053 |
| % Margin | -64.1% | -116% | -104.9% | 28.2% |